Fluidigm Company Profile

Aggregated data from the web about Fluidigm

Company Name	Fluidigm
Website	https://www.fluidigm.com
Snippet	“Fluidigm mass cytometry is an advanced tool for high-content immune monitoring, providing a wealth of information from each sample.” Martin LeBlanc, President and CEO of Caprion Biosciences. “C1 REAP-seq offers a new paradigm to accelerate the identification of. actionable biomarkers and drug targets.”
Type	Public (2011– )
Founded	1999
Revenue	$ 101.937 million (2017)
Website	Official website
Formerly	Mycometrix
Traded as	NASDAQ: FLDMRussell 2000 Component
Key people	S. Christopher Linthwaite (President, CEO)
Headquarters	South San Francisco, California, United States
Number of employees	500 (2014)

Fluidigm is part of the United States company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.